Form4insider filings, from the source

SEC Form 4 · accession 0001213900-26-079764

Jasper Therapeutics, Inc. · JSPR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jul 16, 2026
Accepted (ET)
Jul 20, 2026 · 8:38 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001788028

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to BuyF1$0.774Jul 16, 2026A15,000A——Voting Common Stock15,00015,000D
Non-Voting Convertible Preferred StockF2,F3—Jul 20, 2026P888A——Voting Common Stock888888D

Explanation of responses